Health Economics Assessment of Statin Therapy Initiation Thresholds for Atherosclerosis Prevention in China: a Cost-Effectiveness Analysis

Tianyu Feng, Xiaolin Zhang, Jiaying Xu, Shang Gao, Xihe Yu
doi: https://doi.org/10.1101/2023.08.03.23293584

Article Information

doi 
https://doi.org/10.1101/2023.08.03.23293584
History 
  • August 6, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Tianyu Fenga,
  2. Xiaolin Zhanga,
  3. Jiaying Xua,
  4. Shang Gaoa and
  5. Xihe Yua,*
  1. aSchool of Public Health, Jilin University, Changchun, China
  1. ↵*Corresponding Author:
    Xihe Yu, Ph.D Professor, School of Public Health Jilin University, Changchun City, Jilin Province, China, 130021 Tel: 0431-85619446, E-mail: xhyu{at}jlu.edu.cn
Back to top
Posted August 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Health Economics Assessment of Statin Therapy Initiation Thresholds for Atherosclerosis Prevention in China: a Cost-Effectiveness Analysis
Tianyu Feng, Xiaolin Zhang, Jiaying Xu, Shang Gao, Xihe Yu
medRxiv 2023.08.03.23293584; doi: https://doi.org/10.1101/2023.08.03.23293584
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area